The first study focused on a treatment for critical limb ischemia, or severe blockage in the arteries of the lower legs and feet of elderly patients.
FORBES: Researchers Highlight Warning Signs On Adult Stem Cell Treatments
Study subjects who aren't yet on treatment are being offered antiretroviral drugs.
WSJ: AIDS Study Marks Prevention Breakthrough With Antiretroviral Drugs
But results from a study on 500 patients indicate pacemakers may offer another treatment option.
Consequently, our study challenges current guidelines on the duration of antithrombotic treatment after AVR surgery with biological valves by presenting results suggesting that these patients will gain from an additional 3 months of warfarin treatment in terms of reduced cardiovascular death without risking a significant increase in bleeding events.
FORBES: Longer Warfarin Therapy After Bioprosthetic Aortic Valve Replacement May Be Beneficial
Now, another institution, Nationwide Children's Hospital in Columbus, Ohio, will soon launch another study of Sanfilippo syndrome as it works on a potential treatment.
Dr Tony Rudd, chairman of the group that drew up the guidelines, said they were based on a recent study which suggested patients could benefit from early treatment.
Scott Grundy, a cardiologist at the University of Texas Southwestern who helped write the U.S. cholesterol guidelines, argued that overall the results of the study do show that Tricor was a useful addition on top of current treatment.
Indeed, the minority staff of Congress' Joint Economic Committee has a study underway, and academics are already churning out papers on the proper tax treatment of pretend online worlds with their own economies and commerce.
The current recommendation of 3 months of warfarin treatment after bioprosthetic AVR surgery is primarily based on results from 1 retrospective study with a limited number of events.
FORBES: Longer Warfarin Therapy After Bioprosthetic Aortic Valve Replacement May Be Beneficial
Results of a study released last month, showed life expectancy of those with HIV who are on anti-retroviral treatment, has improved.
The interpretation of the evidence obtained in this study, based on the use of advanced analytical methods, supports the hypothesis of an intentional therapeutic treatment, but alternative post-mortem practices are not ruled out.
In a mid-stage study, 13 of 15 patients who received Soliris did not require further treatment for aHUS. Based on some back-of-the-envelope math based on the incidence of aHUS in France and Italy, Sanford C.
应用推荐